| Literature DB >> 19143533 |
Wu Yang1, Zheming Ruan, Yufeng Wang, Katy Van Kirk, Zhengping Ma, Brian J Arey, Christopher B Cooper, Ramakrishna Seethala, Jean H M Feyen, John K Dickson.
Abstract
The trisubstituted pyrimidine 1 was identified through high-throughput screening as a novel calcium-sensing receptor (CaSR) antagonist. Small molecule CaSR antagonists and/or negative allosteric modulators have the potential to act as an anabolic agent for the treatment of osteoporosis. The investigation of structure-activity relationships around 1 resulted in the identification of 18c and 18d, which showed efficacy at promoting PTH release in vivo and exhibited improved potency and solubility over the original lead 1.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19143533 DOI: 10.1021/jm801178c
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446